YAKOV RYABOV: Open Payments
NPI 1912909615 · WHEELING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,883 in 92 payments from 17 companies in 2025. Trend: 2023 $1,076 · 2024 $1,522 · 2025 $1,883
Food & beverage: $1,883
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $304 |
| ABBVIE INC. | 14 | $241 |
| AstraZeneca Pharmaceuticals LP | 10 | $213 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $168 |
| Phathom Pharmaceuticals, Inc. | 9 | $159 |
| Novo Nordisk Inc | 6 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $118 |
| Teva Pharmaceuticals USA, Inc. | 4 | $86 |
| Ardelyx, Inc. | 4 | $82 |
Products named: Korlym, JARDIANCE, CAPLYTA, Kerendia, VOQUEZNA, FARXIGA, CREON, Ozempic.
Industry payments across IL — which companies pay providers there.
